Dermatology, Procedural Dermatology · Greenville, SC
NPI
1215989587
Since 2006
Specialty
Dermatology, Procedural Dermatology
Code 207NS0135X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
213 Mills Ave
Greenville, SC, 29605
Phone (864) 272-3300
Groups this clinician bills Medicare through
Medicare paid, 2024
$994K
20,174 services
Medicare patients, 2024
2,928
Average age 76
Drug cost, 2024
$1.6M
8,726 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert M Rogers was code 17003 (destruction skin lesion), 5,877 times for 951 patients. In total Robert M Rogers billed 20,174 services in 80 codes, and Medicare paid $994K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 5,877 | 951 | $4.69 | $28K |
| 99213 Office E&M - Established | Office | 3,633 | 2,403 | $57.66 | $209K |
| 96910 Skin | Office | 3,565 | 90 | $83.56 | $298K |
| 17000 Destruction Skin Lesion | Office | 1,649 | 1,244 | $38.18 | $63K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 850 | 161 | $0.68 | $574 |
| 11102 Skin Biopsy | Office | 712 | 632 | $60.96 | $43K |
| 17110 Destruction Skin Lesion | Office | 597 | 523 | $76.32 | $46K |
| 12032 Wound Repair - All Levels | Office | 372 | 297 | $209.50 | $78K |
| 99203 Office E&M - New | Office | 300 | 300 | $71.01 | $21K |
| 99212 Office E&M - Established | Office | 252 | 218 | $39.48 | $9,949 |
| 96372 Injection Administration | Office | 237 | 155 | $9.45 | $2,241 |
| 99214 Office E&M - Established | Office | 222 | 139 | $89.18 | $20K |
| 11602 Skin Lesion Excision | Office | 198 | 165 | $91.85 | $18K |
| 17004 Destruction Skin Lesion | Office | 196 | 152 | $118.61 | $23K |
| 36415 Venipuncture Blood Collection | Office | 165 | 73 | $8.55 | $1,410 |
By year: 2022 $995K for 19,299 services; 2023 $1.0M for 20,517 services; 2024 $994K for 20,174 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 165 | 73 | $8.55 | $1,410 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert M Rogers prescribed most often to Medicare patients was Cephalexin, with 1,495 prescriptions and refills. In total Robert M Rogers wrote 8,726 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cephalexin Generic | 1,495 | 1,503 | 983 | $4,243 |
| Triamcinolone Acetonide Generic | 919 | 1,079 | 475 | $13K |
| Doxycycline Hyclate Generic | 615 | 822 | 170 | $12K |
| Betamethasone Dipropionate Generic | 577 | 636 | 262 | $25K |
| Ketoconazole Generic | 520 | 603 | 175 | $5,462 |
| Mupirocin Generic | 509 | 509 | 410 | $3,115 |
| Ciclopirox Ciclopirox Olamine | 496 | 547 | 194 | $14K |
| Fluticasone Propionate Generic | 494 | 550 | 284 | $11K |
| Clobetasol Propionate Generic | 395 | 438 | 199 | $14K |
| Minoxidil Generic | 269 | 468 | 67 | $1,569 |
| Methotrexate Methotrexate Sodium | 238 | 369 | 52 | $4,198 |
| Minocycline Hcl Generic | 193 | 276 | 49 | $3,402 |
| Clindamycin Phosphate Generic | 186 | 211 | 84 | $7,272 |
| Hydroxyzine Hcl Generic | 175 | 213 | 45 | $3,587 |
| Ciclopirox Generic | 166 | 176 | 69 | $5,581 |
Brand drugs: 186 claims; generic drugs: 8,540 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Robert M Rogers were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.